BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 7, 2026
Breaking News: Best of BioWorld Science: Q1
Breaking News: Best of BioWorld: Q1
Breaking News: Best of BioWorld Science: Q1
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
FDA grants orphan drug designation to Pluristem's PLX-PAD for severe preeclampsia
Jan. 4, 2016
Auxilium to return U.S. and Canadian rights for Stendra to Vivus
Jan. 4, 2016
Bristol-Myers Squibb patents MGAT2 inhibitors
Dec. 31, 2015
FDA grants rare pediatric disease designation to RGX-111 for MPS I
Dec. 31, 2015
HDAC inhibitor AR-42 prevents cancer cachexia in animal models
Dec. 31, 2015
French scientists describe GPBAR1 agonists
Dec. 30, 2015
Agios Pharmaceuticals starts phase I trial of pyruvate kinase deficiency candidate
Dec. 30, 2015
TWi Biotechnology reports interim data from phase II AC-201 CR study in gout patients
Dec. 29, 2015
Novartis describes nonsense mutation suppressors
Dec. 24, 2015
Amicus Therapeutics to begin phase I/II study of ATB-200
Dec. 24, 2015
Previous
1
2
…
347
348
349
350
351
352
353
354
355
…
1790
1791
Next
RSS